Developing a European research network to address unmet needs in anxiety disorders
Developing a European research network to address unmet needs in anxiety disorders
Anxiety disorders are common, typically have an early onset, run a chronic or relapsing course, cause substantial personal distress, impair social and occupational function, reduce quality of life, and impose a substantial economic burden: they are often comorbid with major depression, bipolar disorder, schizophrenia, substance misuse and physical illness, and are associated with increased risks of suicidal behaviour. As such, anxiety disorders should be regarded as a significant public health problem. However the causes of anxiety disorders remain largely unknown, which hinders accurate diagnosis, the prediction of prognosis, and the development of refined treatment approaches. In clinical practice, many patients with anxiety disorders do not present or are not recognised, the standard of care they receive is often sub-optimal, and the effectiveness of pharmacological and psychological treatment interventions in real-world clinical practice can be disappointing. The current substantial unmet public health, clinical and research needs in anxiety disorders could be addressed in part by developing independent collaborative European networks.
anxiety disorders, costs, impairment, public health
2312-2317
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Pallanti, S.
4aec04d9-7f22-407d-b7f9-2aef98f0cc11
Zwanzger, P.
240623d6-352a-4b15-887e-5edab442ec86
December 2013
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Pallanti, S.
4aec04d9-7f22-407d-b7f9-2aef98f0cc11
Zwanzger, P.
240623d6-352a-4b15-887e-5edab442ec86
Baldwin, D.S., Pallanti, S. and Zwanzger, P.
(2013)
Developing a European research network to address unmet needs in anxiety disorders.
Neuroscience & Biobehavioral Reviews, 37 (10), part 1, .
(doi:10.1016/j.neubiorev.2013.01.009).
(PMID:23313646)
Abstract
Anxiety disorders are common, typically have an early onset, run a chronic or relapsing course, cause substantial personal distress, impair social and occupational function, reduce quality of life, and impose a substantial economic burden: they are often comorbid with major depression, bipolar disorder, schizophrenia, substance misuse and physical illness, and are associated with increased risks of suicidal behaviour. As such, anxiety disorders should be regarded as a significant public health problem. However the causes of anxiety disorders remain largely unknown, which hinders accurate diagnosis, the prediction of prognosis, and the development of refined treatment approaches. In clinical practice, many patients with anxiety disorders do not present or are not recognised, the standard of care they receive is often sub-optimal, and the effectiveness of pharmacological and psychological treatment interventions in real-world clinical practice can be disappointing. The current substantial unmet public health, clinical and research needs in anxiety disorders could be addressed in part by developing independent collaborative European networks.
This record has no associated files available for download.
More information
Published date: December 2013
Keywords:
anxiety disorders, costs, impairment, public health
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 367929
URI: http://eprints.soton.ac.uk/id/eprint/367929
ISSN: 0149-7634
PURE UUID: 0e0a1e95-5190-40cd-9d4c-02f784251058
Catalogue record
Date deposited: 09 Sep 2014 12:43
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
S. Pallanti
Author:
P. Zwanzger
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics